Anapharm Bioanalytics - Anapharm Europe S.L.U.
Anapharm Bioanalytics is a European specialized bioanalytical CRO supporting innovative biotechnology and pharmaceutical companies from preclinical development to clinical studies. The company provides high-quality bioanalysis and bioanalytical services for small molecules and biologics, with expertise in LC-MS/MS, ligand-binding assays (ELISA and MSD) and cell-based assays. Anapharm supports preclinical and clinical programmes with services including pharmacokinetics (PK), immunogenicity (ADA/NAb), pharmacodynamics (PD) and biomarker analysis. The organisation combines strong scientific and regulatory expertise with a flexible and collaborative approach particularly suited for early-stage and innovation-driven companies requiring responsive project management and tailored scientific support. Anapharm Bioanalytics operates internationally with a strong European focus and extensive experience supporting innovative drug development programmes.
Services from this partner are open to EIC beneficiaries at the stages listed on each service page. Where EIC ACCESS+ applies, co-funding covers 50% of the full amount.
